Skip to main content
. 2023 Aug 1;9(8):e18848. doi: 10.1016/j.heliyon.2023.e18848

Fig. 7.

Fig. 7

Assessment of tumor immune microenvironment and immunotherapeutic response in distinct groups. (A–J) Correlation of ICD_score with 28 immune cells. (K) Comparison of immune score in high-risk and low-risk patients. (L) Differential expression of immune checkpoint molecules in the high- and low-risk groups. (M − P) Differential levels of IPS with CTLA-4 (pos/neg)/PD-1 (pos/neg) in different score groups. pos: positive, neg: negative. IPS: immunophenoscore.